Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Eslicarbazepine Acetate in Refractory Partial Seizures
NCT00957047Phase 3Completed
- Sponsor
- BIAL
- Start
- Jul 2004
- Primary completion
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of eslicarbazepine acetate in partial epilepsy, sponsored by BIAL. Started Jul 2004; status: completed.
02
Drugs
eslicarbazepine acetate
03
Conditions
partial epilepsy
Beyond the preview
Go deeper on NCT00957047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00957047.